SEC14-like lipid binding 3, also known as SEC14L3 or TAP50, is a member of the SEC14 family of proteins, which are characterized by their ability to bind and transfer lipids. These proteins play critical roles in cellular lipid metabolism and homeostasis, influencing a wide array of biological processes.SEC14L3, in particular, has been principally studied in the context of hepatic function. It is abundantly expressed in the liver, suggesting its involvement in liver-specific processes or diseases. Preliminary research has suggested that SEC14L3 may play a role in regulating lipid homeostasis and cholesterol biosynthesis in the liver. Dysregulation of these processes is often implicated in various liver diseases, such as steatosis and cirrhosis, as well as systemic conditions like cardiovascular disease.
One of the defining features of SEC14L3 and other SEC14 proteins is the presence of a SEC14 domain, a lipid-binding domain that allows these proteins to interact with and transport lipids. This domain enables SEC14L3 to influence the intracellular distribution of lipids, which can impact lipid signaling and membrane composition.SEC14L3's potential role in disease pathogenesis is still relatively understudied, and many aspects of its function and regulation remain unknown. Additional research is needed to further elucidate the precise roles of SEC14L3 in lipid metabolism and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Enhances lipid metabolism, potentially influencing SEC14L3 activity by altering lipid profiles. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Modifies lipid metabolism, potentially impacting SEC14L3 function. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Lowers cholesterol levels and could indirectly influence SEC14L3 activity through changes in lipid metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Used in diabetes management and can influence lipid metabolism, potentially affecting SEC14L3. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Decreases serum triglycerides and cholesterol, may indirectly modulate SEC14L3 activity by altering lipid profiles. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Lowers cholesterol levels and may indirectly affect SEC14L3 through changes in lipid metabolism. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Used to lower cholesterol and could indirectly influence SEC14L3 activity in lipid metabolism. | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $408.00 | 1 | |
Lowers cholesterol and may indirectly affect SEC14L3 function by modulating lipid metabolism. | ||||||